Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-29 @ 3:15 PM
Study NCT ID:
NCT07043608
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-02
First Post:
2025-06-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
Sponsor:
Kelly Fitzgerald, MD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Clear Cell Renal Cell Cancer (ccRCC) | View |
| None | Clear Cell Renal Carcinoma | View |
| None | Clear Cell Renal Cell Carcinoma Metastatic | View |
| None | Clear Cell Renal Cancer | View |
| None | Bone Metastases of a Malignant Tumor | View |
| None | Clear Cell Renal Cell Carcinoma | View |
| None | Bone, Metastatic Cancer | View |
| None | Metastatic Cancer | View |
| None | Metastatic Renal Cell Carcinoma | View |
| None | Metastases to Bone | View |
Keywords: